BMJ open · 2026
Impact of a clinical pharmacist-led stewardship programme on antibiotic utilisation and clinical outcomes in thoracic surgery: a retrospective interrupted time-series study at a tertiary hospital in China.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Guangjie, Guo Fuying, He Yan, Lu Jianhua, Liu Dong, Yin Xiaoxv
Аннотация
OBJECTIVES: This study aims to assess the impact of clinical pharmacist-led antimicrobial stewardship on antibiotic use and postoperative pulmonary infection in a surgical department.
DESIGN: Retrospective and cross-sectional.
SETTING: A tertiary hospital in Wuhan, China.
PARTICIPANTS: A total of 9157 patients who underwent video-assisted thoracoscopic lung surgery (VATLS) were included (4949 and 4208 pre-implementation and post-implementation).
METHODS: An interrupted time-series design with segmented regression analysis was employed to evaluate changes in antibiotic use intensity (defined daily dose/100 bed-days), antibiotic spectrum coverage (scores/100 bed-days) and postoperative pulmonary infection rate before and after implementation of the stewardship programme. Between-group comparisons of antibiotic use rates and treatment duration were performed using χ2 test, Fisher's exact test, t-test or Mann-Whitney U test, as appropriate.
OUTCOME MEASURES: Antibiotic use intensity (defined daily dose/100 bed-days), antibiotic spectrum coverage (scores/100 bed-days), postoperative pulmonary infection rates, the proportion and the duration of antibiotic use.
RESULTS: Following implementation, antibiotic use intensity decreased immediately by 96.65 defined daily doses/100 bed-days (95% CI -122.56 to -70.74; p<0.001). Antibiotic spectrum coverage (ASC) also showed an immediate reduction of 4.77 scores/100 bed-days (95% CI -6.12 to -3.42; p<0.001), although a gradual upward trend in ASC was observed during the post-implementation period. No significant change was seen for postoperative pulmonary infection rates between the two periods. Prescribing patterns shifted towards narrower-spectrum agents: the proportion of first-generation cephalosporins increased from 17.6% to 45.5% (p<0.001), while usage of fourth-generation cephalosporins (12.3% to 1.5%), β-lactam/β-lactamase inhibitors (63.9% to 12.6%), quinolones (57.4% to 27.4%), carbapenems (0.8% to 0.4%) and glycopeptides (8.2% to 3.1%) declined significantly (all p<0.05). The median duration of antimicrobial therapy was shortened across most antibiotic classes.
CONCLUSION: Clinical pharmacist-led antimicrobial stewardship can reduce the antibiotic use intensity among patients undergoing VATLS in thoracic surgery, decrease the use of broad-spectrum antibiotics and shorten the duration of antibiotic therapy.
DESIGN: Retrospective and cross-sectional.
SETTING: A tertiary hospital in Wuhan, China.
PARTICIPANTS: A total of 9157 patients who underwent video-assisted thoracoscopic lung surgery (VATLS) were included (4949 and 4208 pre-implementation and post-implementation).
METHODS: An interrupted time-series design with segmented regression analysis was employed to evaluate changes in antibiotic use intensity (defined daily dose/100 bed-days), antibiotic spectrum coverage (scores/100 bed-days) and postoperative pulmonary infection rate before and after implementation of the stewardship programme. Between-group comparisons of antibiotic use rates and treatment duration were performed using χ2 test, Fisher's exact test, t-test or Mann-Whitney U test, as appropriate.
OUTCOME MEASURES: Antibiotic use intensity (defined daily dose/100 bed-days), antibiotic spectrum coverage (scores/100 bed-days), postoperative pulmonary infection rates, the proportion and the duration of antibiotic use.
RESULTS: Following implementation, antibiotic use intensity decreased immediately by 96.65 defined daily doses/100 bed-days (95% CI -122.56 to -70.74; p<0.001). Antibiotic spectrum coverage (ASC) also showed an immediate reduction of 4.77 scores/100 bed-days (95% CI -6.12 to -3.42; p<0.001), although a gradual upward trend in ASC was observed during the post-implementation period. No significant change was seen for postoperative pulmonary infection rates between the two periods. Prescribing patterns shifted towards narrower-spectrum agents: the proportion of first-generation cephalosporins increased from 17.6% to 45.5% (p<0.001), while usage of fourth-generation cephalosporins (12.3% to 1.5%), β-lactam/β-lactamase inhibitors (63.9% to 12.6%), quinolones (57.4% to 27.4%), carbapenems (0.8% to 0.4%) and glycopeptides (8.2% to 3.1%) declined significantly (all p<0.05). The median duration of antimicrobial therapy was shortened across most antibiotic classes.
CONCLUSION: Clinical pharmacist-led antimicrobial stewardship can reduce the antibiotic use intensity among patients undergoing VATLS in thoracic surgery, decrease the use of broad-spectrum antibiotics and shorten the duration of antibiotic therapy.